Abel Hall LLC
PROK icon

Abel Hall LLC’s ProKidney PROK Stock Holding History

Abel Hall LLC’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66K Sell
39,747
-36,187
-48% -$61.1K 0.01% 813
2026
Q2 		$155K Buy
+75,934
New +$139K 0.03% 783

Other funds holding PROK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Brown University
Brown University Providence, Rhode Island $147M AUM 5.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Abel Hall LLC's PROK Position: Q3 2026 in Review

Abel Hall LLC reduced its ProKidney (PROK) stake by 48% in Q3 2026, selling an estimated $61.1K and leaving 39,747 shares worth $66K. The position accounts for 0.01% of the portfolio, ranked #813.

Abel Hall LLC first reported a position in PROK in Q2 2026 and has held it in 2 quarters since. The position peaked at $155K in Q2 2026. 42 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Abel Hall LLC held 39,747 shares of ProKidney worth $66K as of Q3 2026.
  • Abel Hall LLC sold 36,187 ProKidney shares in Q3 2026, an estimated $61.1K.
  • ProKidney made up 0.01% of Abel Hall LLC's portfolio in Q3 2026, its #813 holding.
  • Abel Hall LLC first reported a position in ProKidney in Q2 2026 and has held it in 2 quarters since.
  • Abel Hall LLC's ProKidney position peaked at $155K in Q2 2026.
  • 42 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.